title: Is there a causal role for homocysteine concentration in blood pressure? A Mendelian randomization study.
abstract: An understanding of whether homocysteine is a cause or a marker of increased blood pressure is relevant because blood homocysteine can be effectively lowered by safe and inexpensive interventions (e.g., vitamin B-6, B-9, and B-12 supplementation).
  
  
  
  The aim was to assess the causal influence of homocysteine on systolic and diastolic blood pressure (SBP and DBP, respectively) in adults with the use of Mendelian randomization (MR).
  
  
  
  Data from the 1982 Pelotas Birth Cohort (Brazil) were used. A total of 4297 subjects were evaluated in 2004-2005 (mean age: 22.8 y). The association of homocysteine concentration with SBP and DBP was assessed by conventional ordinary least-squares (OLS) linear regression and 2-stage least-squares (2SLS) regression (MR analysis). The single nucleotide polymorphism (SNP) methylenetetrahydrofolate reductase (MTHFR) C677T (rs1801133) was used as proxy for homocysteine concentration. We also applied MR to data from the International Consortium for Blood Pressure (ICBP) genomewide association studies (>69,000 participants) using rs1801133 and additional homocysteine-associated SNPs as instruments.
  
  
  
  In OLS regression, a 1-SD unit increase in log homocysteine concentration was associated with an increase of 0.9 (95% CI: 0.4, 1.4) mm Hg in SBP and of 1.0 (95% CI: 0.6, 1.4) mm Hg in DBP. In 2SLS regression, for the same increase in homocysteine, the coefficients were -1.8 mm Hg for SBP (95% CI: -3.9, 0.4 mm Hg; P = 0.01) and 0.1 mm Hg for DBP (95% CI: -1.5, 1.7 mm Hg; P = 0.24). In the MR analysis of ICBP data, homocysteine concentration was not associated with SBP (β = 0.6 mm Hg for each 1-SD unit increase in log homocysteine; 95% CI: -0.8, 1.9 mm Hg) but was positively associated with DBP (β = 1.1 mm Hg; 95% CI: 0.2, 1.9 mm Hg). The association of genetically increased homocysteine with DBP was not consistent across different SNPs.
  
  
  
  Overall, the present findings do not corroborate the hypothesis that homocysteine has a causal role in blood pressure, especially in SBP.
authors.affiliation: Postgraduate Program in Epidemiology and carolina.borges.mcb@gmail.com.
authors.forename: Maria C
authors.identifier: http://orcid.org/0000-0001-7785-4547
authors.initials: MC
authors.lastname: Borges
authors.affiliation: Postgraduate Program in Epidemiology and.
authors.forename: Fernando P
authors.initials: FP
authors.lastname: Hartwig
authors.affiliation: Postgraduate Program in Epidemiology and Department of Physiology and Pharmacology, Institute of Biology, Universidade Federal de Pelotas, Pelotas, Brazil.
authors.forename: Isabel O
authors.initials: IO
authors.lastname: Oliveira
authors.affiliation: Postgraduate Program in Epidemiology and.
authors.forename: Bernardo L
authors.initials: BL
authors.lastname: Horta
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure; D001795:Blood Pressure Determination; D001938:Brazil; D015331:Cohort Studies; D005260:Female; D006710:Homocysteine / Q000097:blood* / Q000235:genetics; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000209:etiology; D008297:Male; D057182:Mendelian Randomization Analysis; D020641:Polymorphism, Single Nucleotide
chemical_list: D015415:Biomarkers; D006710:Homocysteine
keywords: Mendelian randomization; blood pressure; cohort studies; homocysteine; molecular epidemiology